Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist

Nippon rinsho. Japanese journal of clinical medicine

Volumn 62, Issue 8, 2004, Pages 1504-1509

  Habu, Yasuki ^a   Yoshino, Takuya ^a   Shio, Seiji ^a   Hayakumo, Takanobu ^a   Kawai, Keiichi ^a  

^a Department of Gastroenterology

Author keywords

[No Author keywords available]

Indexed keywords

2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; BENZIMIDAZOLE DERIVATIVE; DRUG DERIVATIVE; ENZYME INHIBITOR; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP; RABEPRAZOLE;

CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG ANTAGONISM; DRUG COMBINATION; ECONOMICS; GASTROESOPHAGEAL REFLUX; HUMAN; JAPAN; META ANALYSIS; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; BENZIMIDAZOLES; COST-BENEFIT ANALYSIS; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FAMOTIDINE; GASTROESOPHAGEAL REFLUX; HISTAMINE H2 ANTAGONISTS; HUMANS; JAPAN; MARKOV CHAINS; META-ANALYSIS; OMEPRAZOLE; PROTON PUMPS; RANDOMIZED CONTROLLED TRIALS;

EID: 4644224776     PISSN: 00471852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (4)